Volume 8, Issue 1 (Continuous publishing 2022)                   Iran J Neurosurg 2022, 8(1): 0-0 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Reihanian Z, Behzadnia H, Alijani B, Jafari S, Yousefzadeh-Chabok S, Ramezani-Shamami M. The Effects of Underlying Comorbidities on Surgical Outcome in Patients With Spondylolisthesis Undergoing Surgical Treatment. Iran J Neurosurg 2022; 8 (1) : 11
URL: http://irjns.org/article-1-310-en.html
1- Guilan Road Trauma Research Center, Guilan University of Medical Sciences, Rasht, Iran and Department of Neurosurgery, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
2- Department of Neurosurgery, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
3- Department of Neurosurgery, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran , Mostafa.shamami1992@gmail.com
Full Text [PDF 714 kb]   (340 Downloads)     |   Abstract (HTML)  (1079 Views)
Full Text:   (490 Views)
1. Introduction
Patients with spondylolisthesis often do not require surgical treatment and most of the patients can be treated and improved through conservative therapies [12]. In cases requiring surgical intervention, the optimal choice of patients based on the stage of the disease and the presence of underlying comorbidities can lead to the desired outcome of surgery [3]. Those resistant to conservative management or with the progressive disease require surgical intervention; however, there is disagreement about the type of surgical treatment. Nonetheless, there is a greater tendency to use internal fixation of the vertebrae [4]. Overall, it should be noted that therapeutic messages, in addition to the stage of the lesion and its grade, also depend on several other factors, such as the patient’s underlying condition [5, 6]. In other words, exposure to underlying comorbidities, such as inflammatory and degenerative disorders may increase the likelihood of a poorer postsurgical prognosis [7]. In this regard, the role of progressive and chronic underlying disorders, such as diabetes mellitus, hypertension, or coagulative disorders has been investigated [8, 9]. However, we know very little about how such underlying disorders affect the outcome of conservative or surgical treatments. Understanding the factors affecting the results of surgery can help to improve the results, and in this case, the underlying diseases, especially chronic cases, as well as the chronically drugs used are very important. The aim of this study was to evaluate the role of underlying risk factors, such as diabetes mellitus, hypertension, and anticoagulant conditions (such as aspirin) in worsening outcomes after surgery in patients with spondylolisthesis.
2. Methods and Materials/Patients
This cross-sectional study was conducted on 130 patients suffering from spondylolisthesis and scheduled for surgery. According to baseline characteristics, 65 patients with a history of diabetes mellitus, hypertension, and receiving aspirin were categorized as the case group, and 65 sex- and age-matched individuals without such comorbidities as the control group. The exclusion criteria were bleeding diseases or underlying diseases other than diabetes and hypertension (such as hemophilia, etc.) and the use of drugs that affect blood coagulation. Initially, the records of these patients were followed up from the hospital registration system. The studied background information, including age, gender, Body Mass Index (BMI), and duration of surgery was collected by reviewing the patients’ hospital recorded files. Furthermore, the outcomes studied included 1) severity of preoperative and postoperative radicular pain based on the Visual Analogue Scale (VAS) scoring system (ranging from 0 as no pain to 10 as the most severe pain could be described), 2) discharge from the surgical site, and 3) wound healing that was determined based on interviews with patients and physical examination of the surgical site. 
For statistical analysis, the results were presented as Mean±SD for quantitative variables and were summarized by frequency (percentage) for categorical variables. Continuous variables were compared using a t-test or Mann-Whitney test whenever the data did not appear to have normal distribution or when the assumption of equal variances was violated across the study groups. P-values of ≤0.05 were considered statistically significant. For the statistical analysis, the SPSS software version 23 for windows (IBM, Armonk, New York) was used.
3. Results
The two groups with and without comorbidities were matched for baseline characteristics, including gender, mean age, mean BMI, and time of operation (Table 1).


In the case and control groups, the Mean±SD score of preoperative pain score was 7.28±1.18 and 7.26±0.85, respectively with no significant difference between the two groups (P=0.932). However, the Mean±SD postoperative VAS pain score was 5.26±0.85 and 2.97±0.96, respectively, which in the case group was significantly higher than the control group (P=0.001). In the case and control groups, the frequency of discharge from the operation site was 12.3% and 4.6%, respectively, which was not statistically significant despite the numerical difference (P=0.115). Meanwhile, the rate of non-healing wounds at the site of surgery was significantly higher in the case group than in the control group (20.0 versus 6.2%, P=0.019). In a multivariate logistic regression model and in the presence of underlying factors, including sex, age, BMI, and duration of surgery, the presence of risk factors for diabetes, hypertension, and aspirin use was found to be potential risk factors for the non-healing wound after surgery (OR=0.241, P=0.020) (Table 2), also, in the multivariate linear regression analysis, the presence of such risk factors could predict postoperative pain intensity (beta=-2.309, P=0.001) (Table 3).




4. Discussion
In patients with spondylolisthesis, both conservative and surgical approaches are considered based on the stage of the disease. However, in addition to the technical characteristics of the surgery and the stage of the disease, the underlying characteristics of the patients may also affect the therapeutic prognosis. In this regard, some studies have indicated that the surgical prognosis is worse in diabetic and hypertensive patients and also preoperative medical treatments, such as anticoagulants may be effective in the prognosis of the disease. We compared the clinical outcome of patients undergoing surgery in two groups of patients who were diabetic/hypertensive/aspirin user and patients without these risk factors. In this study, three main outcomes were considered, including the improvement of patients’ pain, healing of the patient’s wound, and secretion of fluid from the surgical site. In this regard, we showed that, firstly, the presence of underlying risk factors for diabetes mellitus, hypertension, and aspirin use (in patients with high coagulation diseases) not only delays wound healing but also improves radicular pain intensity due to spondylolisthesis in patients with risk factors. Although many studies have been performed on the results of various conservative and surgical interventions in patients with spondylolisthesis, few studies have been conducted to indicate which underlying risk factors can affect the prognosis of this surgery.
The results of these studies have been very contradictory. Khan et al. in contrast to our study observed no difference between the diabetic and non-diabetic groups in terms of clinical outcomes. Similarly, no difference was observed between the two groups in terms of the need for reoperation or postoperative complications [10] and a history of diabetes had no effect on exacerbation of poor prognosis. Oster et al. reported that a history of diabetes or smoking did not affect the prognosis of surgery in these patients [11]. However, Nagata et al. reported worse ODI (Oswestry Disability Index) scores and lower quality of life in diabetic patients than non-diabetic patients within one year after surgery [12]. In the study by Moazzeni et al., diabetic and non-diabetic patients who performed fusion one year after surgery showed a significant difference. Diabetic patients had a much higher pain score than non-diabetics within one year after surgery [13]. In addition, in an analytical study by Freedman et al., diabetic patients were at higher risk for side effects and adverse postoperative outcomes for spondylolisthesis due to older age and higher BMI [14]. 
In a review study by Luo et al., length of hospital stay, mortality, and risk of venous thrombosis were higher in diabetic patients with spondylolisthesis [15]. 
Regarding the effect of underlying risk factors on surgical outcomes in patients with spondylolisthesis, due to the high susceptibility of diabetic and hypertensive patients to exacerbation of inflammatory responses, they are less prone to pain relief after surgery or lack of wound healing. This is especially true for diabetics. Therefore, the worse outcome of surgery in patients with these risk factors will be completely predictable.
5. Conclusion
In patients with spondylolisthesis and candidates for surgical treatment, a history of diabetes mellitus, hypertension, and aspirin use can be associated with a worse prognosis, including no improvement in pain and delayed wound healing. 
Limitations
This study had a small sample size because those with bleeding disorders, including patients with hemophilia and thalassemia or underlying diseases other than diabetes and hypertension, and also those using drugs affecting blood coagulation, such as warfarin and heparin, were excluded from the study. Considering the persistent pain among the diabetics, the comparison of pain was performed using VAS score in patients with and without diabetes and hypertension. Furthermore, the required data considering the outcomes of aspirin in the patients were not available in the hospital records; therefore, we could not evaluate this variable. Prospective studies are recommended to consider this important outcome in patients.

Ethical Considerations
Compliance with ethical guidelines

This article was approved by the Ethical Research Comitee of Guilan University of Medical Sciences, Rasht (Code: IR.GUMS.REC.1400.592). 

Funding
The article was extracted from the PhD dissertation the sixth author (Mostafa Ramezani-Shamami) at Department of Neurosurgery, Poursina Hospital, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

Authors' contributions
Conceptualization and design: Zohair Reihanian; Data collection: Mostafa Ramezani-Shamami; Data analysis and interpretation: Babak Alijani; Drafting the article: All authors; Critically revising the article: Seyfollah Jafari; Approving the final version of the manuscript: All authors.

Conflict of interest
The authors declared no conflict of interest. 


References
  1. Saleh I, Librianto D. Surgical treatment of spondylolisthesis using long arm screw: A literature review. Annals of Medicine and Surgery. 2021; 73:103200. [DOI:10.1016/j.amsu.2021.103200] [PMID] [PMCID]
  2. Xu X, Li X, Yang T. A systematic review and meta-analysis of the clinical efficacy of anterior lumbar interbody fusion in the treatment of orthopedic spondylolisthesis. Annals of Palliative Medicine. 2021; 10(12):12607-17. [DOI:10.21037/apm-21-3330] [PMID]
  3. Steinhaus ME, Vaishnav AS, Shah SP, Clark NJ, Chaudhary CB, Othman YA, et al.  Does loss of spondylolisthesis reduction impact clinical and radiographic outcomes after minimally invasive transforaminal lumbar interbody fusion? The Spine Journal. 2022; 22(1):95-103. [DOI:10.1016/j.spinee.2021.06.009] [PMID]
  4. Reisener MJ, Pumberger M, Shue J, Girardi FP, Hughes AP. Trends in lumbar spinal fusion-a literature review. Journal of Spine Surgery. 2020; 6(4):752-61. [DOI:10.21037/jss-20-492] [PMID] [PMCID]
  5. Miyashita T, Ataka H, Kato K, Tanno T. Good 5-year postoperative outcomes after facet fusion using a percutaneous pedicle screw system for degenerative lumbar spondylolisthesis. Neurosurgical Review. 2022; 45(3):2269-76. [DOI:10.1007/s10143-022-01747-x] [PMID]
  6. Mooney J, Michalopoulos GD, Alvi MA, Zeitouni D, Chan AK, Mummaneni PV, et al. Minimally invasive versus open lumbar spinal fusion: A matched study investigating patient-reported and surgical outcomes. Journal of Neurosurgery Spine. 2022; 1-14. [DOI:10.3171/2021.10.SPINE211128] [PMID]
  7. Weinstein JN, Lurie JD, Tosteson TD, Hanscom B, Tosteson AN, Blood EA, et al. Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis. The New England journal of Medicine. 2007; 356(22):2257-70. [DOI:10.1056/NEJMoa070302] [PMID] [PMCID]
  8. Badhiwala JH, Karmur BS, Hachem LD, Wilson JRF, Jiang F, Jaja B, et al. The effect of older age on the perioperative outcomes of spinal fusion surgery in patients with lumbar degenerative disc disease with spondylolisthesis: A propensity score-matched analysis. Neurosurgery. 2020; 87(4):672-8. [DOI:10.1093/neuros/nyz444] [PMID]
  9. Zhong W, Liang X, Luo X, Huang T, Quan Z. Complications rate of and risk factors for the unplanned reoperation of degenerative lumbar spondylolisthesis in elderly patients: A retrospective single-centre cohort study of 33 patients. BMC Geriatrics. 2020; 20(1):301. [DOI:10.1186/s12877-020-01717-2] [PMID] [PMCID]
  10. Khan JM, Michalski J, Basques BA, Louie PK, Chen O, Hayani Z, et al. Do clinical outcomes and sagittal parameters differ between diabetics and nondiabetics for degenerative spondylolisthesis undergoing lumbar fusion? Global Spine Journal. 2020; 10(3):286-93.[DOI:10.1177/2192568219850090] [PMID] [PMCID]
  11. Oster BA, Kikanloo SR, Levine NL, Lian J, Cho W. Systematic review of outcomes following 10-year mark of spine patient outcomes research trial (SPORT) for degenerative spondylolisthesis. Spine (Phila Pa 1976). 2020; 45(12):820-4. [DOI:10.1097/BRS.0000000000003485] [PMID]
  12. Nagata K, Nakamoto H, Sumitani M, Kato S, Yoshida Y, Kawamura N, et al. Diabetes is associated with greater leg pain and worse patient-reported outcomes at 1 year after lumbar spine surgery. Scientific Reports. 2021; 11(1):8142. [DOI:10.1038/s41598-021-87615-y] [PMID] [PMCID]
  13. Moazzeni K, Kazemi KA, Khanmohammad R, Eslamian M, Rostami M, Faghih-Jouibari M. Comparison of surgical outcome between diabetic versus nondiabetic patients after lumbar fusion. International Journal of Spine Surgery. 2018; 12(4):528-32. [DOI:10.14444/5064] [PMID] [PMCID]
  14. Freedman MK, Hilibrand AS, Blood EA, Zhao W, Albert TJ, Vacarro A, et al. The impact of diabetes on the outcomes of surgical and nonsurgical treatment of patients in the spine patient outcomes research trial. Spine. 2011; 36(4):290-307. [DOI:10.1097/BRS.0b013e3181ef9d8c] [PMID] [PMCID]
  15. Luo W, Sun R, Jiang H, Ma X. The effect of diabetes on perioperative complications following spinal surgery: A meta-analysis. Therapeutics and Clinical Risk Management. 2018; 4:2415-23. [DOI:10.2147/TCRM.S185221] [PMID] [PMCID]
 
Type of Study: Research | Subject: Spine

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and Permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Neurosurgery

Designed & Developed by: Yektaweb